Ex vivo inhibition of β-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist

Author: Albert D. H.   Magoc T. J.   Menacherry S. D.   Morgan D. W.   Sun E.   Reyes A. E.   Kleinert H. D.   Carter G. W.   Summers J. B.  

Publisher: Springer Publishing Company

ISSN: 1023-3830

Source: Inflammation Research, Vol.46, Iss.7, 1997-07, pp. : 272-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content